NeuroPace
NeuroPace

NeuroPace

DR52Ahrefs DR: 52/100. Above median. Measured by Ahrefs. Median 44.Agent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Speed42Site Speed: 42/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Develops a brain-computer interface for treating epilepsy.

Website
1997Active248Mountain View, United States

About

NeuroPace develops and commercializes the RNS System, an FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity. This system is designed for adults with drug-resistant focal epilepsy, offering significant seizure reduction and improved quality of life through personalized stimulation and data-driven insights for physicians.

Key facts

At-a-glance profile data

Website
neuropace.com
Headquarters
Mountain View, United States
Founded
1997
Employees
248
Total funding
$475M (IPO)
Business model
B2B

Funding rounds

Funding rounds raised by NeuroPace
DateRoundAmountPost-moneyLead investors
20 Jul 2023IPO$100M$375M-
1 Jan 2017Series E$115M--
1 Jan 2014Series D$100M--
1 Jan 2010Series C$75M--
1 Jan 2007Series B$50M--
1 Jan 2005Series A$25M--
1 Jan 2000Seed$10M--

Tech stack

Detected on neuropace.com, last scanned 9 Sept 2026. Run your own scan

Frontend
jQuery
Analytics
Google Tag Manager, Hotjar
SEO
Yoast SEO
CMS / Builders
WordPress
Hosting
AWS
Email provider
Mimecast
Cookie consent
Osano
Add first review

Frequently asked

How much funding has NeuroPace raised?

NeuroPace has raised a total of $475M in funding. The most recent round on record is IPO.

How many employees does NeuroPace have?

NeuroPace has approximately 248 people on record.